Formulation Composition, Manufacturing Process, and Characterization of Poly(lactide-co-glycolide) Microparticles

Injectable long-acting formulations, specifically poly(lactide-co-glycolide) (PLGA) based systems, have been used to deliver drugs systematically for up to 6 months. Despite the benefits of using long-acting formulations, the development of clinical products and the generic versions of existing form...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Control Release
Auteurs principaux: Park, Kinam, Otte, Andrew, Sharifi, Farrokh, Garner, John, Skidmore, Sarah, Park, Haesun, Jhon, Young Kuk, Qin, Bin, Wang, Yan
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904638/
https://ncbi.nlm.nih.gov/pubmed/33148404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.10.044
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires